Details
Stereochemistry | RACEMIC |
Molecular Formula | C19H18N2O4 |
Molecular Weight | 338.3572 |
Optical Activity | ( + / - ) |
Defined Stereocenters | 0 / 1 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
COCC1CN(C(=O)O1)C2=CC=C(OCC3=CC=CC(=C3)C#N)C=C2
InChI
InChIKey=MVVJINIUPYKZHR-UHFFFAOYSA-N
InChI=1S/C19H18N2O4/c1-23-13-18-11-21(19(22)25-18)16-5-7-17(8-6-16)24-12-15-4-2-3-14(9-15)10-20/h2-9,18H,11-13H2,1H3
Molecular Formula | C19H18N2O4 |
Molecular Weight | 338.3572 |
Charge | 0 |
Count |
|
Stereochemistry | RACEMIC |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 1 |
E/Z Centers | 0 |
Optical Activity | ( + / - ) |
CNS Activity
Approval Year
PubMed
Title | Date | PubMed |
---|---|---|
Some biochemical aspects of the potential benefit of associating MD780515 with tricyclic antidepressants. | 1981 Oct |
|
Neuropharmacological profile of MD 780515, a new reversible inhibitor of type A monoamine oxidase. | 1982 Oct |
|
SL25.1131 [3(S),3a(S)-3-methoxymethyl-7-[4,4,4-trifluorobutoxy]-3,3a,4,5-tetrahydro-1,3-oxazolo[3,4-a]quinolin-1-one], a new, reversible, and mixed inhibitor of monoamine oxidase-A and monoamine oxidase-B: biochemical and behavioral profile. | 2004 Sep |
Patents
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/6538844
40 mg as a single dose
Route of Administration:
Oral
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 15:16:45 GMT 2023
by
admin
on
Fri Dec 15 15:16:45 GMT 2023
|
Record UNII |
V6FT1QJ7VL
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NCI_THESAURUS |
C667
Created by
admin on Fri Dec 15 15:16:45 GMT 2023 , Edited by admin on Fri Dec 15 15:16:45 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
5004
Created by
admin on Fri Dec 15 15:16:45 GMT 2023 , Edited by admin on Fri Dec 15 15:16:45 GMT 2023
|
PRIMARY | |||
|
73815-11-9
Created by
admin on Fri Dec 15 15:16:45 GMT 2023 , Edited by admin on Fri Dec 15 15:16:45 GMT 2023
|
PRIMARY | |||
|
Cimoxatone
Created by
admin on Fri Dec 15 15:16:45 GMT 2023 , Edited by admin on Fri Dec 15 15:16:45 GMT 2023
|
PRIMARY | |||
|
CHEMBL2104092
Created by
admin on Fri Dec 15 15:16:45 GMT 2023 , Edited by admin on Fri Dec 15 15:16:45 GMT 2023
|
PRIMARY | |||
|
C026234
Created by
admin on Fri Dec 15 15:16:45 GMT 2023 , Edited by admin on Fri Dec 15 15:16:45 GMT 2023
|
PRIMARY | |||
|
C90879
Created by
admin on Fri Dec 15 15:16:45 GMT 2023 , Edited by admin on Fri Dec 15 15:16:45 GMT 2023
|
PRIMARY | |||
|
277-613-7
Created by
admin on Fri Dec 15 15:16:45 GMT 2023 , Edited by admin on Fri Dec 15 15:16:45 GMT 2023
|
PRIMARY | |||
|
52542
Created by
admin on Fri Dec 15 15:16:45 GMT 2023 , Edited by admin on Fri Dec 15 15:16:45 GMT 2023
|
PRIMARY | |||
|
100000081057
Created by
admin on Fri Dec 15 15:16:45 GMT 2023 , Edited by admin on Fri Dec 15 15:16:45 GMT 2023
|
PRIMARY | |||
|
DTXSID50868273
Created by
admin on Fri Dec 15 15:16:45 GMT 2023 , Edited by admin on Fri Dec 15 15:16:45 GMT 2023
|
PRIMARY | |||
|
V6FT1QJ7VL
Created by
admin on Fri Dec 15 15:16:45 GMT 2023 , Edited by admin on Fri Dec 15 15:16:45 GMT 2023
|
PRIMARY | |||
|
SUB06281MIG
Created by
admin on Fri Dec 15 15:16:45 GMT 2023 , Edited by admin on Fri Dec 15 15:16:45 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
ENANTIOMER -> RACEMATE | |||
|
ENANTIOMER -> RACEMATE |
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |